Search by Drug Name or NDC
NDC 00023-3616-70 LATISSE 0.3 mg/mL Details
LATISSE 0.3 mg/mL
LATISSE is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is BIMATOPROST.
MedlinePlus Drug Summary
Topical bimatoprost is used to treat hypotrichosis (less than the normal amount of hair) of the eyelashes by promoting the growth of longer, thicker, and darker lashes. Topical bimatoprost is in a class of medications called prostaglandin analogs. It works by increasing the number of eyelash hairs that grow and the amount of time that they grow.
Related Packages: 00023-3616-70Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Bimatoprost Topical
Product Information
| NDC | 00023-3616 |
|---|---|
| Product ID | 0023-3616_2c93eda7-3ae0-4804-a557-3a19364f06e7 |
| Associated GPIs | 90734020002020 |
| GCN Sequence Number | 064746 |
| GCN Sequence Number Description | bimatoprost DROP W/APP 0.03 % TOPICAL |
| HIC3 | T0D |
| HIC3 Description | TOPICAL HYPERTRICHOTIC AGENTS, EYELASHES |
| GCN | 16219 |
| HICL Sequence Number | 022000 |
| HICL Sequence Number Description | BIMATOPROST |
| Brand/Generic | Brand |
| Proprietary Name | LATISSE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | bimatoprost |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 0.3 |
| Active Ingredient Units | mg/mL |
| Substance Name | BIMATOPROST |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Prostaglandin Analog [EPC], Prostaglandins [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022369 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00023-3616-70 (00023361670)
| NDC Package Code | 0023-3616-70 |
|---|---|
| Billing NDC | 00023361670 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-70) / 3 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2009-01-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 41.5019 |
| Pricing Unit | ML |
| Effective Date | 2023-03-22 |
| NDC Description | LATISSE 0.03% EYELASH SOLUTION |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis